Skip to content

Clark Hill Advises HCW Biologics in Up to $10 Million Debt Financing

November 11, 2026

Clark Hill’s Capital Markets team, led by Jim Groth and Jeny Zarmon, served as issuer’s counsel to HCW Biologics Inc. (Nasdaq: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer, and senescence-associated dysplasia, in its secured debt financing of up to $10 million.

The financing provided $3 million at closing and access to an additional $7 million, subject to certain conditions, to support the company’s clinical development programs and general corporate purposes.

Additional details regarding the transaction were announced in the company’s press release.

Related Practice Areas

Subscribe for the latest

Subscribe

Related

Legal Updates

Five-Year Route to Permanent UK Residence Set to Change

Earned settlement reforms introduce 3-, 5-, 10- and 20-year routes based on salary, contribution and character, with implementation now expected by early January 2027.

Explore more
Event

2026 California Labor & Employment Law Symposium

Clark Hill’s in-person symposium is designed to help employers stay ahead of California’s challenging and evolving workplace legal landscape. This business-focused program will deliver timely updates and concrete guidance on the issues that matter most to HR professionals, in-house counsel, and business leaders.

Explore more
Legal Updates

November 10th Disclosure Date Survives Ninth Circuit Challenge to California Climate Disclosure Laws

Ninth Circuit ruling keeps SB 253 Scope 1 and 2 reporting in effect while finding Scope 3 and SB 261 climate disclosures likely unconstitutional under review.

Explore more

The Clark Hill approach is equally pragmatic and growth-minded, which is why we understand our clients’ toughest business challenges. Our multidisciplinary, global team of advisors focuses on smart legal solutions, delivered simply.

© 2026 Clark Hill PLC.